TITLE

Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia

PUB. DATE
June 2009
SOURCE
Indian Journal of Ophthalmology;Jun2009, Vol. 57 Issue 3, p241
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
38606142

 

Related Articles

  • Combination photodynamic therapy and bevacizumab for choroidal neovascularization associated with toxoplasmosis. Rishi, Pukhraj; Venkataraman, Anusha; Rishi, Ekta // Indian Journal of Ophthalmology;Jan2011, Vol. 59 Issue 1, p62 

    A 14-year-old girl presenting with visual loss in both eyes was diagnosed to have healed toxoplasma retinochoroiditis in the right eye with active choroidal neovascularization (CNV) secondary to toxoplasmosis in the left. She underwent combination photodynamic therapy (PDT) and intravitreal...

  • PDT and Avastin Treats Neovascular AMD.  // Review of Ophthalmology;Mar2007 Part 1 of 2, Vol. 14 Issue 3, p97 

    The article cites a study which found that combining photodynamic therapy (PDT) with verteporfin and intravitreal bevacizumab could enhance the treatment of neovascular age-related macular degeneration (AMD). Patients with juxtafoveal or subfoveal choroidal neovascularization underwent treatment...

  • Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Choroidal Neovascularization Due to Sorsby Macular Dystrophy. Kapoor, Kapil G.; Bakri, Sophie J. // Journal of Ocular Pharmacology & Therapeutics;May2013, Vol. 29 Issue 4, p444 

    Purpose: To report the first case of intravitreal bevacizumab and ranibizumab to treat choroidal neovascularization secondary to Sorsby macular dystrophy. Case: A 57-year-old male with metamorphopsia, color vision deficits, and ocular family history of Sorsby macular dystrophy was found to have...

  • Terapia antiangiogênica associada à fotocoagulação a laser no tratamento de membrana neovascular sub-retiniana: relato de caso. Pereira, JosÉ Alexandre Bastos; Camarota, Isabela Soutello // Arquivos Brasileiros de Oftalmologia;2011, Vol. 74 Issue 5, p371 

    The aim of this report is to describe a case of age-related macular degeneration with juxtafoveal subretinal neovascular membrane, initially treated with intravitreal bevacizumab (Avastin®) and afterwards with focal photocoagulation laser therapy. The efficacy of the initial and complementary...

  • Response to 'Bevacizumab and type 1 idiopathic macular telangiectasia'. Ooto, S; Takayama, K; Yoshimura, N // Eye;Dec2011, Vol. 25 Issue 12, p1665 

    A response by S. Ooto and colleagues to a letter to the editor about their article "Intravitreal bevacizumab for type 1 idiopathic macular telangiectasia" in the 2010 issue is presented.

  • Combined photodynamic therapy and intravitreal bevacizumab as treatment for nonresponsive myopic choroidal neovascularization. Chhablani, Jay Kumar // Oman Journal of Ophthalmology;Sep2010, Vol. 3 Issue 3, p159 

    A letter to the editor is presented which discusses the use of intravitreal bevacizumab and photodynamic therapy (PDT) as a combined treatment for a 59-year-old male patient with resistant myopic choroidal neovascularization in his left eye.

  • Vitreous, Choroid, and Retina.  // Current Medical Literature: Ophthalmology;2008, Vol. 18 Issue 2, p62 

    The article presents abstracts on vitreous, choroid and retina which include retinal detachment and prophylaxis in type 1 Stickler syndrome, the incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002 and Randomized multicenter trial of more intense and standard...

  • Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab. Shibeeb, O'Sam; Vaze, Anagha; Gillies, Mark; Gray, Timothy // Case Reports in Ophthalmological Medicine;2014, p1 

    We report a patient with macular oedema due to type 1 macular telangiectasia responding to intravitreal aflibercept injection. A 51-year-old man was diagnosed with type 1 idiopathic macular telangiectasia (IMT) in the right eye. The macular oedema was refractory to initial treatment with...

  • Retina. Mark T.#Dunbar // Review of Optometry;5/15/2005, Vol. 142 Issue 5, p61 

    Reports on the aid of photodynamic therapy (PDT) in conjunction with other agents for newer retinal treatments. Efficacy of PDT in combination with Kenalog (triamcinolone acetonide) in reducing subretinal fluid that leads to better restoration of vision; Retrospective analysis of patients for...

  • Combination therapy with verteporfin and anti-VEGF agents in neovascular age-related macular degeneration: where do we stand? Kaiser, Peter K. // British Journal of Ophthalmology;Feb2010, Vol. 94 Issue 2, p143 

    The author discusses the use of combination therapy in the treatment of neovascular age-related macular degeneration (AMD) using verteporfin photodynamic therapy (PDT) and anti-vascular endothelial growth factor (anti-VEGF) agents. He says that combining PDT with anti-VEGF agents is more...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics